Lakeway, TX -- (SBWIRE) -- 02/22/2013 -- vb-news.net, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-
SWINGPLANE VENTURES (OTC:SWVI) jumped up 52.30% to $0.655 on a traded volume of 12.05 million shares. Swingplane Ventures, Inc. announced the completion of all documentation required to file the Super 8K for the acquisition of Mid Americas Corp. Mid Americas Corp. has finalized its audited financial statements and the Company will file the Super 8K today with the Securities and Exchange Commission. Under the terms of the acquisition agreement, the Company will issue a total of 100,000,000 shares of its common stock and 5,000,000 shares of Series A preferred stock to the shareholders of Mid Americas Corp. and will cancel a total of 300,000,000 shares originally issued for the option.
How Should Investors Trade SWVI After The Solid Jump? Let’s Find Out Here
Attitude Drinks Inc. (NDA) (OTC:ATTD) declined 50% to $0.0001 on a traded volume of 14.91 million shares. So far this year, the stock is down over 50%. The 52-week range for the stock is $0.0 and $0.01. Attitude Drinks Incorporated is a development-stage company. The Company focuses on the non-alcoholic single serving beverage business, developing and marketing of milk based products in two segments: sports recovery and functional dairy.
Is ATTD Ready To Jump Again After The Solid Momentum? Get Free Trend Analysis Here
SOLO INTERNATIONAL (OTC:SLIO) declined 10% to $0.0090 on a traded volume of 3.71 million shares. The 52-week range for the stock is $0.01 and $0.13. The 50-Day Moving Average and 200-Day Moving Average prices is $0.01 and $0.03 respectively. Solo International, Inc. is an exploration stage company, focuses on the acquisition, exploration, production, development, and operation of mining properties in Quebec, Canada.
Is SLIO Buy After The Recent Price Movement? Find Out Here
Advaxis, Inc. (OTC:ADXS) jumped up 12.08% to $0.134 on a traded volume of 2.38 million shares. Advaxis announced that the Brown University Oncology Research Group will be coordinating a Phase 1/2 study of ADXS-HPV in 25 patients with HPV-associated anal cancer. Dr. Howard Safran, professor of medicine, will be principal investigator. Patients will be treated at Rhode Island Hospital and The Miriam Hospital.
Is ADXS Buy After The Recent Price Movement? Find Out Here
vb-news.net’s team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.
The assembled information disseminated by vb-news.net is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. vb-news.net does expect that investors will buy and sell securities based on information assembled and presented in vb-news.net. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)